Related Experiment Videos
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer
A W Partin1, R H Getzenberg, M J CarMichael
1Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
Cancer Research
|February 15, 1993
Summary
Researchers identified specific nuclear matrix proteins (NMP) in human prostate tissues. A novel protein, PC-1, was found exclusively in prostate cancer, suggesting its potential role in disease progression.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- The nuclear matrix is crucial for nuclear structure and DNA organization.
- Previous studies demonstrated tissue-specific nuclear matrix proteins (NMP) in rat models.
- Understanding NMP in human prostate tissues is essential for cancer research.
Purpose of the Study:
- To compare NMP patterns in normal human prostate, benign prostatic hyperplasia (BPH), and prostate cancer.
- To identify specific NMP that differentiate these tissue types.
- To explore the role of NMP in prostate disease progression.
Main Methods:
- Analysis of fresh human prostate tissues (normal, BPH, cancer) from 21 patients.
- High-resolution two-dimensional polyacrylamide gel electrophoresis for NMP profiling.
- Identification of proteins by molecular weight and isoelectric point.
Main Results:
- 14 distinct proteins showed consistent presence or absence across tissue types.
- A novel protein, PC-1 (M(r) 56,000, pI 6.58), was detected in all 14 prostate cancer samples.
- PC-1 was absent in normal prostate (0/13) and BPH (0/14) tissues.
- NMP patterns suggest BPH shares nuclear matrix alterations with prostate cancer.
Conclusions:
- Specific NMP patterns distinguish normal prostate, BPH, and prostate cancer.
- PC-1 is a potential biomarker for prostate cancer.
- Findings support a model where BPH progression involves nuclear matrix changes similar to cancer.